Teladoc Health, Inc.
Income Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $606.9M | $613.8M | $642.3M | $626.4M | $631.9M | $629.4M | $640.5M | $640.5M |
| Cost of Revenue | $190.8M | $197.5M | $197.0M | $187.2M | $190.5M | $196.8M | $188.9M | $179.7M |
| Gross Profit | $416.1M | $416.3M | $445.2M | $439.3M | $441.4M | $432.5M | $451.6M | $460.8M |
| Gross Margin | 68.6% | 67.8% | 69.3% | 70.1% | 69.8% | 68.7% | 70.5% | 71.9% |
| Operating Expenses | ||||||||
| Research & Development | $62.9M | $67.9M | $71.6M | $67.6M | $68.8M | $70.0M | $76.8M | $72.4M |
| SG&A Expense | $104.0M | $102.1M | $108.4M | $102.6M | $108.1M | $112.8M | $100.0M | $114.2M |
| Operating Income | $-37.1M | $-61.8M | $-36.0M | $-52.0M | $-54.4M | $-120.6M | $-48.2M | $-44.4M |
| Operating Margin | -6.1% | -10.1% | -5.6% | -8.3% | -8.6% | -19.2% | -7.5% | -6.9% |
| Interest Expense | — | — | — | — | — | $5.8M | $6.8M | $5.7M |
| Pretax Income | $-37.9M | $-60.8M | $-33.6M | $-50.2M | $-40.4M | $-111.3M | $-48.2M | $-32.5M |
| Income Tax Expense | $997.0K | $3.0M | $-8.5M | $-715.0K | $-7.8M | $-18.3M | $238.0K | $780.0K |
| Net Income | $-38.9M | $-63.8M | $-25.1M | $-49.5M | $-32.7M | $-93.0M | $-48.4M | $-33.3M |
| Net Margin | -6.4% | -10.4% | -3.9% | -7.9% | -5.2% | -14.8% | -7.6% | -5.2% |
| EPS (Basic) | $-0.21 | $-0.36 | $-0.14 | $-0.28 | $-0.19 | $-0.53 | $-0.27 | $-0.19 |
| EPS (Diluted) | $-0.21 | $-0.36 | $-0.14 | $-0.28 | $-0.19 | $-0.53 | $-0.27 | $-0.19 |
| Shares Outstanding (Basic) | 181.0M | 179.1M | 176.2M | 176.9M | 175.9M | 174.2M | 170.6M | 171.5M |
| Shares Outstanding (Diluted) | 181.0M | 179.1M | 176.2M | 176.9M | 175.9M | 174.2M | 170.6M | 171.5M |
| Dividends Per Share | — | — | — | — | — | — | — | — |